Gadeta is a research and development company, discovers and develops immunotherapies for cancer. The work of the Company is based on the discoveries regarding the role of γδ T cell receptors (TCRs) in the broad recognition of both hematological and solid tumor cells and their potential use for the treatment of advanced malignancies.